The European Union is investigating the reports of suicidal thoughts associated with the use of Ozempic® (semaglutide) and Saxenda® (liraglutide).
The US FDA has received 60 reports of suicidal ideation for patients on semaglutide and 70 on liraglutide.
Yet, Boris Johnson called semaglutide a “wonder drug” in his first Mail article as a columnist that h…